Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
23 results
D2.545 - Perception of adult patients in an allergy clinic after using Scribe artificial intelligence, our experience
D2.546 - Ethical Impact of Generative AI in Clinical Practice for Asthma and Allergy
D2.547 - The Transparent and Credible AI for Clinical Protocols
D2.548 - Expert Evaluation of Dialogue Quality and Clinical Reasoning in a Hybrid Multilingual LLM–Algorithm Allergy Decision-Support System: A Pilot Study of 34 Real-World Cases
D3.306 - Veno-Venous ECMO For Aprotinin-Induced Perioperative Anaphylaxis
D3.308 - Kounis Syndrome: the allergic myocardial infarction
D3.313 - Recurrent Anaphylaxis with Elevated Baseline Tryptase Revealing Hereditary Alpha-Tryptasemia with Mast Cell Activation
D3.314 - Rapid desensitization to intravenous risankizumab after anaphylaxis in a patient with Crohn’s disease: a case report
D3.315 - Management of Drug Hypersensitivity Reactions in an Oncology Patient: An Atypical Case of Omeprazole Allergy with Pantoprazole Tolerance
D3.317 - Linguistic Validation of the Turkish Version of the Mastocytosis Control Test (MCT)
D3.318 - Evaluation of Clinical Predictors and Serum Tryptase Levels in Systemic Mastocytosis
D3.319 - Clinical Data of Drug Induced Anaphylaxis according to the standardized European Anaphylaxis Registry (NORA)
D3.320 - Anaphylaxis by Chlorhexidine: A case series
D3.321 - Cardiac arrest after Iodixanol: a case of non-IgE mediated mast cell activation
D3.307 - Chlorhexidine-triggered anaphylaxis in a child with multisystem allergy and sickle cell disease: a diagnostic pitfall
D3.309 - Basophil Activation Test Detects Rocuronium Allergy During the Post-Anaphylactic Refractory Period: A PAMA Case Report
D3.322 - Successful management with Omalizumab and high-dose venom immunotherapy in a patient with Kounis Syndrome and Clonal Mast Cell Activation Syndrome
D3.455 - Comparative Characterization of Olfactory Dysfunction in Mouse Models of Eosinophilic Chronic Rhinosinusitis
D3.456 - BEAMER: A multidisciplinary model for disease-agnostic adherence integrating chronic rhinosinusitis: development and prospective study
D3.451 - Long-term follow-up of ASA therapy after desensitization in patients with chronic rhinosinusitis with nasal polyps indicates high rate of treatment discontinuation
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download